000 | 02224na a2200277 4500 | ||
---|---|---|---|
003 | PC3665 | ||
005 | 20180417112257.0 | ||
008 | 130622s2012 xxx||||| |||| 00| 0 eng d | ||
040 | _cH120 | ||
041 | _aeng, spa | ||
100 |
_9387 _aCortijo Cascajares, Susana _eFarmacia |
||
100 |
_aAmuriza Chicharro, Natalia de _91997 _eFarmacia |
||
100 |
_9875 _aHerreros de Tejada López-Coterilla, Alberto _eFarmacia |
||
100 |
_aAguilella Vizcaíno, María José _91920 _eFarmacia |
||
100 |
_91925 _aGoyache Goñi, María del Puy _eFarmacia |
||
100 |
_aGastalver Martín, Cristina _92001 _eFarmacia |
||
245 | 0 | 0 |
_aAnalysis of Panitumumab Use in the Clinical Practice _h[artículo] |
260 |
_bAtención Farmaceútica, _c2012 |
||
300 | _a2012:14(4):270-5. | ||
500 | _aFormato Vancouver: Gastalver Martín C, Cortijo Cascajares N, De Amuriza Chicharro N, Aguilella Vizcaíno MJ, Goyache-Goñi MP, Herreros de Tejada López Coterilla A. Análisis de utilización de Panitumumab en la práctica clínica. Aten Farm. 2012:14(4):270-5. | ||
520 | _aObjective: To understand panitumumab use and safety in the clinical practice. Method: We conducted a retrospective study in the years 2009 and 2010, which included all those patients who had received panitumumab during this period. The collected variables were age, prior treatments, number of cycles, dose, pattern, changes in dose and pattern, adverse effects and cause for treatment suspension. Results: We found that the majority of patients received panitumumab after other treatments failed. 48% of the population took panitumumab combined with other medications. The most common adverse reactions were dermatological. The adverse reaction profile did not vary in a significant way between the two types of administration. 13.4% of patients who received panitumumab were suffering from head and neck cancer Conclusions: We observed an extended use of panitumumab in a polytherapy regime. This last one was more effective than in monotherapy, with a slightly higher toxicity. | ||
710 |
_9320 _aServicio de Farmacia Hospitalaria |
||
773 | 0 | _g | |
856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/3/pc3665.pdf _ySolicitar documento |
||
942 |
_n0 _2ddc _cART |
||
999 |
_c3665 _d3665 |